fda warning bpc-157 compounding safety risks Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr. The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link

SKU: 44970803016 · From www.asociacionchamorro.org